A new study published in the Journal of the National Cancer Institute reaffirms that diabetes drugs containing thiazolidinedione (Actos and Avandia) — which accounts for up to 20 percent of the drugs prescribed to diabetics in the United States — are linked to a two to three times increase in risk of developing bladder cancer as compared to …
The Food and Drug Administration (FDA) issued a warning on June 2011 that Actos (pioglitazone) has been associated with an increased risk of bladder cancer. Actos is an antidiabetic medication that is used to treat people with type 2 diabetes mellitus. It is not surprising that Actos lawsuits have sprung up due to the Actos bladder cancer risk.
Actos is a prescription medication designed to help control symptoms of type 2 diabetes. Actos works by increasing sensitivity to insulin and how the body reacts to insulin. Actos side effects vary based on the individual and their health history and range from mild to life-threatening. Studies demonstrated patients who took Actos maybe at an increased risk of developing bladder cancer.
On June 15, 2011, the U.S. Food & Drug Administration (FDA) issued a safety communication stating that use of Actos for more than one year may be associated with an increased risk of bladder cancer. The June safety communication was a follow-up to one the agency issued in September 2010 after preliminary data from a …
Bladder cancer is a condition in which abnormal cells grow rapidly in the organ. Symptoms to look for with the disease include blood in the urine, a frequent need to urinate and getting a lot of urinary tract infections. Pain in the back near the kidneys, swelling in the lower legs, pelvic masses, bone pain …
There is a consensus in the medical field that the exact causes of bladder cancer are unknown. However, in June 2011, the Food and Drug Administration (FDA) issued a warning to patients with type 2 diabetes. A review of a recent study revealed a possible link between taking Actos, a drug prescribed to type 2 diabetes patients, and developing bladder cancer.
Cancer of the bladder can be caused by cigarette smoking, radiation treatment, exposure to chemicals at work, and as a side effect of chemotherapy. Sometimes, and especially in women, bladder cancer originates from frequently recurring bladder and urinary tract infections. An additional cause of bladder cancer is the drug Actos (or pioglitazone).
Actos is a medication that is frequently used as part of an exercise and diet program for the treatment of type-2 diabetes. On occasion, the drug is used to treat fatty liver disease. On June 15, 2011 the FDA announced that using Actos for one year or more could drastically raise ones chances of developing bladder cancer. As a result, Actos lawsuits are being filed nationwide.
People who take Actos for over a year are an increased risk of developing bladder cancer says FDA.
Actos is a prescription medication used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes. It works on two of the common problems that lead to high blood sugar in type 2 diabetes. First by helping your body better use the insulin it makes, and secondly it also stops your liver from making more sugar when it doesn’t need to. Other Actos side effects include congestive heart failure.
If you or a loved one developed Actos bladder cancer call the Law Offices of Sadaka Associates today!
Bladder cancer risks aren’t likely to send the diabetes drug pioglitazone (Actos) down the same path as rosiglitazone (Avandia), according to an exclusive InFocus report from the American Diabetes Association meeting.